Ant Insurance Uses AI to Help Partner Insurers Process 7.25 Million Health Claims in 2024, Up 55% YoY
In 2024, leading insurers in China processed 7.25 million health claims through Ant Insurance, Ant Group's online insurance brokerage platform, marking a 55% year-over-year increase. Total health claim payouts on the platform reached RMB 9.2 billion (USD 1.3 billion). This growth is driven by ongoing innovations in product offerings and user experience, which build trust and meet user needs, while also reflecting the increasing demand for health insurance services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250309812706/en/
Partner insurers processed 7.25 million health claims through Ant Insurance in 2024, up 55% year-over-year. (Photo: Business Wire)
The trend is expected to accelerate as China’s demographic patterns shift. By around 2035, over 400 million people, or more than 30% of the population, will be aged 60 or older, according to projections from China’s National Health Commission. As healthcare needs expand, commercial health insurance is becoming an essential complement to the country's basic medical system.
Ant Group has been leveraging innovative technologies to drive the digital transformation of the healthcare sector, with health insurance playing a key role.
Early in 2018, Ant Insurance introduced Haoyibao, a flagship health insurance product developed in partnership with leading insurers in China. It was the first in the country to offer guaranteed renewal for six consecutive years with payouts of up to RMB 4 million (USD 550,000). Over time, Haoyibao has been continually upgraded to support a wider range of people and health conditions. As a bestselling product, it has helped millions of families manage the financial burden of medical expenses.
With technologies like AI, Ant Insurance has streamlined every step of the insurance process - from product selection and planning to management and claims - making insurance services more accessible to the public.
The GoldenChoice feature uses the Ant Insurance Multi-factor Model (AIMM) to compare and select the best insurance products. Meanwhile, the EasyPick AI insurance planner creates personalized plans for users, helping them avoid overbuying or selecting the wrong coverage. In 2024, the AI-powered EasyClaims solution helped 11 partner insurers streamline the claims process for over 85 health insurance products, with AI handling 96% of the 1.62 million claims analysis requests from policyholders.
Further enhancing insurer capabilities, Ant Insurance launched Ant Bridge in September 2024. This open platform integrates AI models and financial intelligence to help insurers provide real-time, personalized responses to customer inquiries, improving service quality and operational efficiency.
Beyond insurance, Ant Group has been actively contributing to the digital transformation of China’s healthcare industry for over a decade. Since launching the country’s first online hospital appointment booking service in 2014, Ant Group’s Alipay digital platform has been assisting hospitals in developing digital services. As of January 2025, Alipay has connected more than 800 million users with services from over 3,600 hospitals.
In September 2024, Ant Group introduced the AI Healthcare Manager within the Alipay app. Available through voice and text interactions, this tool provides users with access to over 30 services, including doctor mapping, medical report interpretation, in-hospital navigation, and personalized medical advice.
Through these ongoing initiatives, Ant Group is contributing to the more efficient use of limited medical resources, with the aim of supporting greater medical inclusion.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250309812706/en/
Contacts
Media Inquiries
Yinan Duan
duanyinan.dyn@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Forrester Announces The EMEA Recipients Of Its 2025 Customer-Obsessed Enterprise Award21.5.2025 12:00:00 EEST | Press release
Forrester (Nasdaq: FORR) today announced that Brenntag and e& are the winners of its 2025 Customer-Obsessed Enterprise Award for Europe, Middle East, and Africa (EMEA). The award recognises organisations that place their customers at the centre of their leadership, strategy, and operations to drive business outcomes, including building sustainable growth, customer loyalty, and employee engagement. Both recipients will be celebrated at CX Summit EMEA, a leading event for CX, B2C marketing, and digital leaders to learn best practices and receive actionable advice, being held in London and digitally from 2–4 June 2025. This year’s recognition highlights two firms: one leading the charge on customer obsession in the B2B sector and the other in B2C. Brenntag, a global leader in chemicals and ingredients distribution, has been selected for embedding customer obsession into its B2B operations spanning 72 countries. The firm earned the award for operationalising customer obsession through key
Legora Attracts $80 Million Series B Funding as Top Global Law Firms and Legal Teams Rush to Adopt Its Collaborative AI21.5.2025 11:00:00 EEST | Press release
Today, Legora announces an $80 million funding round led by ICONIQ and General Catalyst, with continued support from existing investors Redpoint Ventures, Benchmark, and Y Combinator. This latest round is a strong endorsement of Legora’s product quality, velocity and the remarkable traction it has achieved globally—underscored by its rapid progression from inception to Series B in under two years. The deal comes as adoption of legal AI surges across the world. Legora is at the forefront of this shift - with lawyers across 250 firms and legal teams in 20 markets globally making daily use of its platform to review and research with precision, draft smarter, and collaborate seamlessly. Legora operates out of New York, London, and Stockholm, with 100 employees drawn from some of the world’s leading global law firms and tech companies. Max Junestrand, CEO and founder of Legora said: “The investment is a clear validation of the value our product is delivering to lawyers around the world. Whi
SEKISUI CHEMICAL: Victory in German Patent Infringement Lawsuit Concerning PVB Interlayer Films21.5.2025 11:00:00 EEST | Press release
The High Performance Plastics Company (President : Akira Asano) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter “SEKISUI CHEMICAL”) hereby notifies that it has obtained judgments in its favor (hereinafter referred to as “the Judgments”) from the District Court Munich I on April 17, 2025, in the patent infringement litigation (docket No. 7 O 12401/24 and 7 O 12476/24) against Kuraray Europe GmbH (hereinafter referred to as “Kuraray Europe”), a subsidiary of Kuraray Co., Ltd which we previously announced in the press release dated October 16, 2024, titled “Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany.” This judgments found that the sound-insulating wedge products manufactured and sold by Kuraray Europe, namely “‘Trosifol’ The Wedge Acoustic” and “‘Trosifol’ The Wedge Acoustic Shadeband” (hereinafter collectively referred to as “Kuraray Products”) infringe European Patent No.
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom